Editas Medicine (EDIT) EBITDA Margin (QoQ) (2015 - 2025)
Editas Medicine (EDIT) EBITDA Margin (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Editas Medicine | 263.01 Mn | 116.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 111,514.00 |
| Jun 30, 2025 | 19,452.00 |
| Mar 31, 2025 | -148,286.00 |
| Dec 31, 2024 | 10.75 Mn |
| Sep 30, 2024 | -9.36 Mn |
| Jun 30, 2024 | -811,389.00 |
| Mar 31, 2024 | -586,239.00 |
| Dec 31, 2023 | 90,018.00 |
| Sep 30, 2023 | 58,724.00 |
| Jun 30, 2023 | -101,001.00 |
| Mar 31, 2023 | 45,340.00 |
| Dec 31, 2022 | 13.60 Mn |
| Sep 30, 2022 | -13.61 Mn |
| Jun 30, 2022 | -10,295.00 |
| Mar 31, 2022 | -41,581.00 |
| Dec 31, 2021 | 29,971.00 |
| Sep 30, 2021 | 1.40 Mn |
| Jun 30, 2021 | -1.37 Mn |
| Mar 31, 2021 | -29,839.00 |
| Dec 31, 2020 | -59,117.00 |